Sep. 10, 2015—Vanderbilt University researchers have received two major federal grants — totaling $7.6 million over four years — to support groundbreaking research aimed at making genetic information a routine part of patients’ electronic medical records.
May. 7, 2015—A new faculty task force has been appointed to prioritize and refine the eight health-related initiatives in the Academic Strategic Plan and to inventory existing health-related interdisciplinary centers and institutes at Vanderbilt.
Feb. 19, 2015—The Precision Medicine Initiative is a national effort announced by President Obama during his State of the Union address to provide more effective treatment and prevention strategies for individuals by taking into account their unique genetic, environmental and lifestyle factors.
Jun. 13, 2013—Since it was founded in 1963, the Vanderbilt Division of Clinical Pharmacology has pioneered “translational science” and continues to transform medical practice worldwide, speakers at the division’s 50th anniversary scientific symposium said last week.
Nov. 15, 2012—“Personalized medicine—the effort to tailor health care to understand individual patients’ needs, genetic profiles and circumstances—is a big emphasis at the Vanderbilt University Medical Center,” said Jeff Balser, vice chancellor for health affairs and dean of the School of Medicine at Vanderbilt, in his opening statement to a panel discussing personalized medicine at the Global South Summit...
Nov. 15, 2012—Dan Roden, M.D., assistant vice chancellor for Personalized Medicine and William Stokes Professor of Experimental Therapeutics, received a 2012 Distinguished Scientist Award at the annual Scientific Sessions of the American Heart Association (AHA) last week in Los Angeles.
Sep. 12, 2012—Watch video of the Chancellor’s Lecture Series, featuring a talk by Dr. Dan Roden: “Genomes, Hype, and a Realistic Pathway to Personalized Medicine” Roden is widely-recognized for his expertise in clinical, genetic, cellular, and molecular basis of arrhythmia susceptibility and variability responses to arrhythmia therapies. Over the past decade, he has led Vanderbilt’s broader efforts in...